Stigma a major barrier to treatment for pregnant women with addictions
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Dr. Loretta Finnegan, Colleen Dell, and Franco Vaccarino introduced the Canadian Centre for Substance Abuse's new report on treating pregnant women with substance abuse addictions.
Photo Credit: Laura Eggertson Doctors and other health care providers need to check their moral outrage at the door and treat pregnant women addicted to drugs and alcohol with compassion and supportive, team-based care, urges the Canadian Centre on Substance Abuse.
Stigma is one of the biggest barriers to effective treatment for pregnant women who use legal or illegal substances, according to the centre's new report, Licit and Illicit Drug Use During Pregnancy: Maternal, Neonatal and Early Childhood Consequences. Pregnant women's use of tobacco, alcohol and prescription and nonprescription opiods is "a burgeoning epidemic throughout the world," says Dr. Loretta Finnegan, the report's author. Finnegan is the former medical adviser to the director of the Office of Research on Women's Health at the US National Institutes of Health.
"Rather than discouraging discussions of drug use during pregnancy, we should be looking upon this as an opportunity to bring about positive, long-lasting change in the life of the mother and child, through effective In Ontario, the number of babies born with the syndrome has been increasing, says Rita Notarandrea, the deputy CEO of the centre. In 2009-2010, there were 564 reported cases, up from 171 cases in 2003, according to First Do No Harm. That more than three-fold increase is driving concern for ensuring that pregnant women get treatment for their addictions, Notarandrea said.
Before women seek treatment, however, they need to be assured of informed, nonjudgmental care that will support their needs long after the babies are delivered, the report urges. Doctors need to be better informed about the unique treatment needs of women, who progress more quickly than men into alcohol and opioid dependence, as well as into related circulatory disorders, cirrhosis of the liver and hypertension. Women are also at greater risk than men of severe cocaine-related health problems.
Using drugs or alcohol during pregnancy increases the risk of miscarriage, premature labour, and postpartum infections and hemorrhage, and it affects babies' ability to nurse, eliminate and eat, the report says.
"Pregnant women who smoke, who drink, who use prescription or illegal drugs are as deserving of compassion, comprehensive support, interventions and treatment -and perhaps even more so -as anyone else presenting with an addiction issue," Notarandrea told the news conference.
That's because two-thirds of women with substance abuse problems also have concurrent mental health problems, such as depression, anxiety and post-traumatic stress disorder, and a large proportion have been sexually and/or physically abused in childhood or as adults, says Colleen Dell, the Research Chair in Substance Abuse at the University of Saskatchewan in Saskatoon.
"So it's harmful for us to look at pregnant women with addiction issues and assume it's as simple as saying 'For the sake of the baby, stop using'," Dell said.
The intersection of addiction, mental health, trauma and abuse issues makes caring for pregnant women with addictions complex and challenging, she and Finnegan acknowledged. That intersection also makes it vital that women be offered a continuum of team-based care that includes child care, transportation and housing supports, to ensure both mother and child flourish, they said. Those resources, including beds in treatment programs, are often hard for women to access, said Dell.
